Skip to Main Content

With focus on research, development and commercialization of medicines to address critical needs for those living with rare, autoimmune and severe inflammatory diseases, Horizon Therapeutics maintains an impressive reputation among patient advocacy organization and employees.

Join us for a conversation with Timothy P. Walbert, Chairman, President and Chief Executive Officer, Horizon Therapeutics plc to discuss his personal journey and the growth of Horizon, the importance of engaging with and establishing a connection with local communities and the key role that businesses play in laying the groundwork to prop up underserved communities who lack necessary resources to thrive. Tim will be in conversation with moderator Linda Imonti, Office Managing Principal, Chicago, KPMG.

Pricing:
Members: Complimentary
Non-Members: $25

Presenting Sponsor

Season Sponsors

Media Sponsor